Balance Sheet Asahi Kasei Corporation

Stocks

3407

JP3111200006

Diversified Chemicals

Market Closed - Japan Exchange Other stock markets 14:30:00 17/07/2026 HKT			5-day change	1st Jan Change
1,829.50 ^JPY	-2.48%		-0.68%	+31.71%

07-16	Noetra Corp. announced that it has received funding from a group of investors	CI
07-07	Asahi Kasei Constructs New Slitting Facility For SUNFORT DFR In Tainan Taiwan	CI

068d211f427d9c3d4122cd4f18c9b.fOCzm9RkQjpAP5AUd34VF46pMou6ZfSquZb3mwZI4Do.Ps3E-uEhGEsuWeljMSp4RMvmYPPpSKOeia6j9UkmqW0j1fLakw4YayoI_w

Published financial data: ASAHI KASEI CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	2,461B	2,726B	2,785B	3,037B	3,075B
Total Revenues	2,461B	2,726B	2,785B	3,037B	3,075B
Cost of Goods Sold, Total	1,692B	1,953B	1,969B	2,079B	2,066B
Gross Profit	770B	774B	816B	958B	1,009B
Selling General & Admin Expenses, Total	496B	571B	602B	586B	610B
R&D Expenses	71.5B	74.03B	73.35B	80.75B	80.88B
Depreciation & Amortization - (IS)	-	-	-	79.29B	86.25B
Other Operating Expenses, Total	567B	645B	675B	746B	777B
Operating Income	203B	128B	141B	212B	231B
Interest Expense, Total	-3.64B	-5.91B	-7.45B	-9.1B	-12.45B
Interest And Investment Income	5.7B	7.92B	11.19B	13.38B	14.65B
Net Interest Expenses	2.05B	2.01B	3.74B	4.28B	2.2B
Income (Loss) On Equity Invest.	8.88B	923M	-38.11B	-7.19B	8.99B
Currency Exchange Gains (Loss)	-	-2.29B	-	-5.62B	-
Other Non Operating Income (Expenses)	-1.52B	-7.46B	-16.26B	-9.93B	-11.98B
EBT, Excl. Unusual Items	212B	122B	90.12B	193B	230B
Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	27.73B	29.4B	25.32B	32.38B	50.79B
Gain (Loss) On Sale Of Assets	-6.61B	-11.79B	-7.52B	-8.17B	-6.13B
Asset Writedown	-6.81B	-189B	-92.83B	-12.18B	-16.66B
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-11.24B	-11.6B	13.76B	-10.89B	-43.8B
EBT, Incl. Unusual Items	215B	-61.91B	28.84B	195B	215B
Income Tax Expense	51.29B	27.46B	-17.48B	54.2B	51.07B
Earnings From Continuing Operations	164B	-89.37B	46.33B	140B	164B
Net Income to Company	164B	-89.37B	46.33B	140B	164B
Minority Interest	-1.95B	-1.94B	-2.52B	-5.41B	-4.75B
Net Income - (IS)	162B	-91.31B	43.81B	135B	159B
Net Income to Common Incl Extra Items	162B	-91.31B	43.81B	135B	159B
Net Income to Common Excl. Extra Items	162B	-91.31B	43.81B	135B	159B
Per Share Items
Net EPS - Basic	116.68	-65.84	31.6	97.94	116.97
Basic EPS - Continuing Operations	116.68	-65.84	31.6	97.94	116.97
Basic Weighted Average Shares Outstanding	1.39B	1.39B	1.39B	1.38B	1.36B
Net EPS - Diluted	116.68	-65.84	31.6	97.94	116.97
Diluted EPS - Continuing Operations	116.68	-65.84	31.6	97.94	116.97
Diluted Weighted Average Shares Outstanding	1.39B	1.39B	1.39B	1.38B	1.36B
Normalized Basic EPS	94.12	53.37	38.81	83.8	102.59
Normalized Diluted EPS	94.12	53.37	38.81	83.8	102.59
Dividend Per Share	34	36	36	38	42
Payout Ratio	29.15	-53.2	114.05	37.01	34.25
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	351B	305B	323B	398B	428B
EBITA	231B	166B	170B	245B	265B
EBIT	203B	128B	141B	212B	231B
Effective Tax Rate - (Ratio)	23.84	-44.36	-60.62	27.85	23.8
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	131B	74.02B	53.8B	116B	139B
Non-Cash Pension Expense	1.56B	-1.19B	-2.35B	-1.37B	-5.6B
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	98.69B	105B	107B	111B	111B
Maintenance & Repair Expenses, Total	-	-	-	-	-

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	245B	251B	338B	393B	377B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	245B	251B	338B	393B	377B
Accounts Receivable, Total	432B	440B	483B	488B	510B
Total Receivables	432B	440B	483B	488B	510B
Inventory	540B	643B	679B	719B	794B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	117B	154B	150B	169B	185B
Total Current Assets	1,334B	1,488B	1,650B	1,769B	1,865B
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	805B	872B	853B	921B	961B
Long-term Investments	312B	303B	303B	316B	329B
Goodwill	431B	368B	361B	390B	384B
Other Intangibles, Total	406B	369B	394B	541B	534B
Loans Receivable Long-Term	6.23B	8.47B	17.2B	9.56B	10.52B
Deferred Tax Assets Long-Term	54.28B	45.92B	84.56B	69.22B	53.92B
Other Long-Term Assets, Total	-	0	-	-	-
Total Assets	3,349B	3,455B	3,663B	4,015B	4,138B
Liabilities
Accounts Payable, Total	178B	181B	213B	194B	195B
Accrued Expenses, Total	146B	147B	152B	181B	197B
Short-term Borrowings	352B	320B	261B	290B	99.93B
Current Portion of Long-Term Debt	-	40B	30B	20B	30B
Current Portion of Leases	2.22B	6.77B	7.82B	8.05B	9.33B
Current Income Taxes Payable	58.12B	17.49B	17.83B	18.67B	19.7B
Other Current Liabilities	187B	200B	233B	253B	242B
Total Current Liabilities	924B	912B	915B	965B	793B
Long-Term Debt	414B	579B	626B	847B	838B
Long-Term Leases	8.72B	28.53B	30.73B	29.54B	34.34B
Pension & Other Post Retirement Benefits	152B	129B	133B	122B	108B
Deferred Tax Liability Non Current	52.02B	27.77B	20.18B	55.61B	58.48B
Other Non Current Liabilities	79.81B	81.93B	89.26B	82.69B	141B
Total Liabilities	1,630B	1,759B	1,814B	2,101B	1,972B
Common Stock, Total	103B	103B	103B	103B	103B
Additional Paid In Capital	79.89B	79.84B	80.27B	80.32B	80.32B
Retained Earnings	1,282B	1,142B	1,136B	1,191B	1,295B
Treasury Stock	-6.22B	-7.43B	-7.32B	-8.02B	-10.14B
Comprehensive Income and Other	228B	343B	502B	493B	620B
Total Common Equity	1,687B	1,661B	1,813B	1,859B	2,088B
Minority Interest	31.4B	35.09B	35.23B	54.52B	77.19B
Total Equity	1,719B	1,696B	1,849B	1,914B	2,166B
Total Liabilities And Equity	3,349B	3,455B	3,663B	4,015B	4,138B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.39B	1.39B	1.39B	1.36B	1.36B
ECS Total Common Shares Outstanding	1.39B	1.39B	1.39B	1.36B	1.36B
Book Value / Share	1.22K	1.2K	1.31K	1.37K	1.54K
Tangible Book Value	851B	924B	1,059B	929B	1,171B
Tangible Book Value Per Share	613.11	666.73	763.73	683.96	862.99
Total Debt	777B	975B	956B	1,195B	1,011B
Net Debt	533B	724B	617B	802B	634B
Debt Equivalent of Unfunded Proj. Benefit Obligation	151B	103B	91.56B	47.49B	-929M
Minority Interest, Total (Incl. Fin. Div)	31.4B	35.09B	35.23B	54.52B	77.19B
Account Code - Inventory Valuation	-	-	-	-	-
Inventories - Raw Materials, Total	142B	170B	190B	194B	198B
Inventories - Work In Process, Total	146B	162B	172B	184B	226B
Inventories - Finished Goods, Total	253B	310B	317B	342B	370B
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Full Time Employees	46.75K	48.9K	49.3K	50.35K	47.9K
Accumulated Allowance for Doubtful Accounts (Supple)	2.47B	2.57B	2.88B	3.8B	3.81B
Order Backlog	533B	503B	520B	567B	602B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	215B	-61.91B	28.84B	195B	215B
Depreciation & Amortization - CF	120B	139B	153B	153B	163B
Amortization of Goodwill and Intangible Assets - (CF)	28.39B	37.7B	29.6B	32.63B	33.75B
Depreciation & Amortization, Total	148B	177B	182B	186B	196B
(Gain) Loss From Sale Of Asset	13.42B	201B	100B	20.35B	22.79B
(Gain) Loss on Sale of Investments - (CF)	-26.03B	-29.4B	-25.32B	-30.17B	-50.79B
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-8.88B	-923M	38.11B	7.19B	-8.99B
Other Operating Activities, Total	-57.62B	-105B	-30.8B	-42.4B	-47.14B
Change In Accounts Receivable	-45.91B	8.4B	-19.09B	2.82B	-12.38B
Change In Inventories	-73.26B	-84.05B	-16.3B	-32.07B	-76.55B
Change In Accounts Payable	31.58B	-13.12B	16.21B	-5.62B	10.08B
Change in Other Net Operating Assets	-13.28B	-1.32B	21.1B	681M	55.14B
Cash from Operations	183B	90.8B	295B	301B	303B
Capital Expenditure	-142B	-152B	-148B	-202B	-194B
Sale of Property, Plant, and Equipment	1.28B	7.8B	1.18B	723M	5.71B
Cash Acquisitions	-80.91B	-78.42B	-	-191B	-
Divestitures	-	-	-	1.81B	62.6B
Sale (Purchase) of Intangible assets	-27.45B	-20.18B	-24.25B	-16.26B	-17.38B
Investment in Marketable and Equity Securities, Total	31.59B	34.34B	25.88B	30.3B	41.34B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-3.32B	-4.53B	-5.74B	3.61B	-6.36B
Other Investing Activities, Total	52M	-614M	8.04B	-8.47B	876M
Cash from Investing	-221B	-214B	-143B	-381B	-107B
Short Term Debt Issued, Total	94.63B	11B	-	18.84B	-
Long-Term Debt Issued, Total	50.9B	260B	126B	306B	83.11B
Total Debt Issued	146B	271B	126B	325B	83.11B
Short Term Debt Repaid, Total	-	-29.78B	-64.67B	-	-194B
Long-Term Debt Repaid, Total	-51.09B	-75.46B	-94.5B	-102B	-83.92B
Total Debt Repaid	-51.09B	-105B	-159B	-102B	-278B
Issuance of Common Stock	125M	208M	122M	122M	220M
Repurchase of Common Stock	-412M	-1.42B	-12M	-30.02B	-2.34B
Common Dividends Paid	-47.19B	-48.58B	-49.96B	-49.96B	-54.39B
Common & Preferred Stock Dividends Paid	-47.19B	-48.58B	-49.96B	-49.96B	-54.39B
Other Financing Activities, Total	-4.64B	-3.85B	-10.81B	2B	5.73B
Cash from Financing	42.32B	112B	-94.33B	145B	-245B
Foreign Exchange Rate Adjustments	21.03B	15.74B	29.66B	-8.5B	31.16B
Miscellaneous Cash Flow Adjustments	1.11B	212M	-2.44B	134M	-
Net Change in Cash	26.71B	4.96B	85.6B	56.54B	-17.97B
Supplemental Items
Cash Interest Paid	3.65B	5.86B	7.04B	8.55B	11.95B
Cash Income Tax Paid (Refund)	59.14B	111B	34.83B	45.46B	48.76B
Levered Free Cash Flow	23.65B	-90.19B	88.94B	61.52B	17.23B
Unlevered Free Cash Flow	25.93B	-86.5B	93.59B	67.21B	25.02B
Change In Net Working Capital	79.15B	171B	4.61B	33.41B	105B
Net Debt Issued / Repaid	94.43B	165B	-33.67B	222B	-195B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.04	2.36	2.47	3.45	3.54
Return on Total Capital	5.44	3.11	3.21	4.48	4.6
Return On Equity %	10.2	-5.23	2.61	7.46	8.02
Return on Common Equity	10.26	-5.45	2.52	7.35	8.04
Margin Analysis
Gross Profit Margin %	31.27	28.38	29.3	31.55	32.8
SG&A Margin	20.14	20.96	21.61	19.3	19.85
EBITDA Margin %	14.25	11.19	11.6	13.1	13.91
EBITA Margin %	9.39	6.09	6.12	8.05	8.62
EBIT Margin %	8.23	4.71	5.05	6.98	7.52
Income From Continuing Operations Margin %	6.66	-3.28	1.66	4.62	5.32
Net Income Margin %	6.58	-3.35	1.57	4.44	5.16
Net Avail. For Common Margin %	6.58	-3.35	1.57	4.44	5.16
Normalized Net Income Margin	5.31	2.71	1.93	3.8	4.53
Levered Free Cash Flow Margin	0.96	-3.31	3.19	2.03	0.56
Unlevered Free Cash Flow Margin	1.05	-3.17	3.36	2.21	0.81
Asset Turnover
Asset Turnover	0.79	0.8	0.78	0.79	0.75
Fixed Assets Turnover	3.23	3.25	3.23	3.42	3.27
Receivables Turnover (Average Receivables)	6.41	6.25	6.03	6.26	6.16
Inventory Turnover (Average Inventory)	3.31	3.3	2.98	2.97	2.73
Short Term Liquidity
Current Ratio	1.44	1.63	1.8	1.83	2.35
Quick Ratio	0.73	0.76	0.9	0.91	1.12
Operating Cash Flow to Current Liabilities	0.2	0.1	0.32	0.31	0.38
Days Sales Outstanding (Average Receivables)	56.98	58.38	60.66	58.32	59.22
Days Outstanding Inventory (Average Inventory)	110.23	110.54	122.82	122.73	133.66
Average Days Payable Outstanding	33.38	31.85	35.94	35.03	33.13
Cash Conversion Cycle (Average Days)	133.83	137.08	147.54	146.03	159.74
Long Term Solvency
Total Debt/Equity	45.22	57.47	51.69	62.44	46.69
Total Debt / Total Capital	31.14	36.5	34.08	38.44	31.83
LT Debt/Equity	24.58	35.85	35.52	45.81	40.26
Long-Term Debt / Total Capital	16.93	22.76	23.42	28.2	27.45
Total Liabilities / Total Assets	48.68	50.9	49.53	52.33	47.66
EBIT / Interest Expense	55.63	21.73	18.9	23.3	18.57
EBITDA / Interest Expense	96.29	51.63	43.36	43.76	34.34
(EBITDA - Capex) / Interest Expense	57.24	25.91	23.53	21.59	18.79
Total Debt / EBITDA	2.22	3.2	2.96	3	2.37
Net Debt / EBITDA	1.52	2.37	1.91	2.01	1.48
Total Debt / (EBITDA - Capex)	3.73	6.37	5.45	6.09	4.32
Net Debt / (EBITDA - Capex)	2.55	4.73	3.52	4.08	2.71
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.87	10.77	2.14	9.06	1.22
Gross Profit, 1 Yr. Growth %	13.08	0.52	5.45	17.44	5.25
EBITDA, 1 Yr. Growth %	14.98	-13.05	5.88	23.25	7.42
EBITA, 1 Yr. Growth %	17.45	-28.13	2.59	43.56	8.34
EBIT, 1 Yr. Growth %	17.95	-36.66	9.66	50.57	9.1
Earnings From Cont. Operations, 1 Yr. Growth %	99.56	-154.55	-151.84	203.07	16.48
Net Income, 1 Yr. Growth %	102.94	-156.41	-147.97	208.17	17.63
Normalized Net Income, 1 Yr. Growth %	21.69	-43.32	-27.31	114.68	20.57
Diluted EPS Before Extra, 1 Yr. Growth %	102.95	-156.43	-148	209.91	19.43
Accounts Receivable, 1 Yr. Growth %	28.45	1.85	9.76	0.94	4.59
Inventory, 1 Yr. Growth %	12.21	18.94	5.65	5.97	10.34
Net Property, Plant and Equip., 1 Yr. Growth %	12.26	8.26	-2.11	7.89	4.4
Total Assets, 1 Yr. Growth %	14.74	3.15	6.03	9.62	3.06
Tangible Book Value, 1 Yr. Growth %	10.02	8.65	14.56	-12.26	26.02
Common Equity, 1 Yr. Growth %	14.99	-1.57	9.18	2.54	12.32
Cash From Operations, 1 Yr. Growth %	-27.75	-50.45	225.21	2.1	0.54
Capital Expenditures, 1 Yr. Growth %	6.68	6.83	-2.81	36.55	-3.97
Levered Free Cash Flow, 1 Yr. Growth %	-80.24	-481.38	-198.61	-30.82	-71.99
Unlevered Free Cash Flow, 1 Yr. Growth %	-78.7	-433.64	-208.2	-28.19	-62.78
Dividend Per Share, 1 Yr. Growth %	0	5.88	0	5.56	10.53
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.95	13.78	6.37	5.55	5.07
Gross Profit, 2 Yr. CAGR %	6.79	6.62	2.96	11.28	11.18
EBITDA, 2 Yr. CAGR %	8.94	-0.01	-4.05	14.24	15.06
EBITA, 2 Yr. CAGR %	7.6	-8.12	-14.13	21.36	24.71
EBIT, 2 Yr. CAGR %	6.92	-13.57	-16.66	28.49	28.17
Earnings From Cont. Operations, 2 Yr. CAGR %	24.48	4.33	-46.82	25.34	87.88
Net Income, 2 Yr. CAGR %	24.8	6.99	-47.98	21.59	90.39
Normalized Net Income, 2 Yr. CAGR %	7.91	-16.95	-35.81	24.92	60.89
Diluted EPS Before Extra, 2 Yr. CAGR %	24.85	7.02	-47.96	21.97	92.39
Accounts Receivable, 2 Yr. CAGR %	14.52	14.38	5.73	5.26	2.75
Inventory, 2 Yr. CAGR %	6.33	15.53	12.09	5.81	8.13
Net Property, Plant and Equip., 2 Yr. CAGR %	10.99	10.24	2.94	2.77	6.13
Total Assets, 2 Yr. CAGR %	8.93	8.79	4.58	7.81	6.29
Tangible Book Value, 2 Yr. CAGR %	14.92	9.33	11.56	0.26	5.15
Common Equity, 2 Yr. CAGR %	11.42	6.39	3.67	5.81	7.32
Cash From Operations, 2 Yr. CAGR %	21.35	-40.17	26.94	82.21	1.31
Capital Expenditures, 2 Yr. CAGR %	1.4	6.76	1.9	15.2	14.51
Levered Free Cash Flow, 2 Yr. CAGR %	-11.35	-13.19	93.92	-17.41	-55.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	-3.05	-15.69	90	-11.85	-48.3
Dividend Per Share, 2 Yr. CAGR %	0	2.9	2.9	2.74	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.28	8.21	9.76	7.26	4.09
Gross Profit, 3 Yr. CAGR %	3.79	4.66	6.23	7.57	9.24
EBITDA, 3 Yr. CAGR %	3.82	1.05	1.91	4.3	11.92
EBITA, 3 Yr. CAGR %	0.31	-5.94	-4.68	1.91	16.85
EBIT, 3 Yr. CAGR %	-1.12	-10.2	-6.43	1.5	21.67
Earnings From Cont. Operations, 3 Yr. CAGR %	3.03	-5.45	-17.36	-5.01	22.31
Net Income, 3 Yr. CAGR %	3.15	-4.22	-18.11	-5.87	20.25
Normalized Net Income, 3 Yr. CAGR %	-1.15	-12.93	-20.56	-4.01	23.45
Diluted EPS Before Extra, 3 Yr. CAGR %	3.36	-4.18	-18.08	-5.67	21.12
Accounts Receivable, 3 Yr. CAGR %	7.56	10.13	12.82	4.11	5.03
Inventory, 3 Yr. CAGR %	8.13	10.38	12.13	10.01	7.3
Net Property, Plant and Equip., 3 Yr. CAGR %	9.02	10.07	5.96	4.57	3.31
Total Assets, 3 Yr. CAGR %	9.15	6.97	7.86	6.23	6.2
Tangible Book Value, 3 Yr. CAGR %	-0.04	12.79	11.05	2.98	8.2
Common Equity, 3 Yr. CAGR %	6.9	6.91	7.31	3.29	7.93
Cash From Operations, 3 Yr. CAGR %	-4.75	-9.98	5.19	18.05	49.45
Capital Expenditures, 3 Yr. CAGR %	7.44	3.18	3.47	12.34	8.42
Levered Free Cash Flow, 3 Yr. CAGR %	-35.62	44.18	-9.42	37.53	-42.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	-34.29	46.37	-8.38	37.37	-33.87
Dividend Per Share, 3 Yr. CAGR %	0	1.92	1.92	3.78	5.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.5	5.95	5.11	7.14	7.86
Gross Profit, 5 Yr. CAGR %	5.58	3.58	3.45	7.26	8.18
EBITDA, 5 Yr. CAGR %	5.51	-0.44	0.6	6.13	6.98
EBITA, 5 Yr. CAGR %	5.49	-5.16	-5.74	4.15	6.14
EBIT, 5 Yr. CAGR %	4.94	-8.35	-7.65	3.64	6.12
Earnings From Cont. Operations, 5 Yr. CAGR %	7.03	-12.29	-20.92	5.84	14.78
Net Income, 5 Yr. CAGR %	7.08	-11.71	-21.56	5.37	14.76
Normalized Net Income, 5 Yr. CAGR %	5.75	-10.78	-16.83	0.59	5.35
Diluted EPS Before Extra, 5 Yr. CAGR %	7.22	-11.59	-21.45	5.53	15.27
Accounts Receivable, 5 Yr. CAGR %	7.54	5.36	6.82	8.16	8.68
Inventory, 5 Yr. CAGR %	9.28	12.3	9.7	8.52	10.52
Net Property, Plant and Equip., 5 Yr. CAGR %	7.65	9.17	6.55	7.09	6.03
Total Assets, 5 Yr. CAGR %	8.24	8.32	7.3	7.31	7.23
Tangible Book Value, 5 Yr. CAGR %	4.32	1.15	4.45	7.6	8.65
Common Equity, 5 Yr. CAGR %	7.95	5.23	5.59	6.47	7.31
Cash From Operations, 5 Yr. CAGR %	1.64	-18.33	6.85	19.36	3.62
Capital Expenditures, 5 Yr. CAGR %	11.38	12.88	5.18	7.83	7.75
Levered Free Cash Flow, 5 Yr. CAGR %	-18.83	-7.14	0.07	15.37	-32.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-17.99	-8.31	0.48	19.5	-27.12
Dividend Per Share, 5 Yr. CAGR %	7.21	1.15	1.15	2.25	4.32